Not that it really matters, but..... look at my history of posts...... before I came to SPPI I was in INO and an active poster on that board.... I think my yahoo alias goes back to 2009.
Second, you can go to SA website and read an article I wrote on Inovio on April 22, 2013 "The Disruptive Potential of Inovio's Syncon DNA vaccines"...
No duplicate alias will spend 2 - 3 weeks to write an article like I did,... You can then do comparison of the commentary of my INO posts with the posts listed under the published article.... with a little homework you'll see you're dealing with one and only person....
I wrote a fairly lengthy reply to your post,.. but the POS YMB rules deleted it..... so much for 10-15 minutes of my time...
So, here are the "Cliff Notes" version
* I'm reasonably confident of my investment in SPPI, but not calm and smooth as I'd be with it in a CD (but then I'd agitated by lack of return on my investment)... i.e. I sleep at night
* I don't have total trust in the management team... can't say that about any company leadership,... nor myself
* I have a great paying job, and other investments, SPPI isn't my only egg
* I haven't met with SPPI leadership...
* I like segment of the drug industry SPPI is in: Oncology / Hematology (plenty of unmet needs)
* I especially like SPPI's strategy... this is a great strategy for becoming a multi-billion $$ company
* I like that that they have 5 approved drugs... soon to be 6.
* I like that I'm buying SPPI at a significant discount due to the current concerns,.. and the significant short interest
* I'm expect Raj to retire in the next 1 - 2 years....
I think that hedge fund companies like Millennium with significant stock positions in SPPI are concurrently shorting SPPI,.. profiting from a long/short strategy...
I have acquired about 95k shares,.. but my subsequent monthly purchases are relatively small.... My target is around 100k shares which I should achieve by Q2 next year...
Agree with the assessment of SPPI's achievements and potential! With 30% of the stock sold short, it appears like a hedge fund or two are in control of the trading.... I continue to acquire shares with the conviction that as the uncertainties are cleared up,... the market sentiment will also change...
Their response to the positive news?? "Bah humbug,.. Raj is the worst CEO,...." What a bunch of toads!
Short mantra....... "Must control the message,.. must control the message....... folks you didn't see anything here today.... nothing happening... move on... pay no attention..."
Short trolls don't know it, but there's an infra-red dot "painted" on the back of their heads..... but let them have their limited troll frolic....
Meanwhile SPPI is executing on their strategy.... Q1-Q2, 2015, we should be resolution on the Fusilev patent dispute,... next a SPI-2012 Ph III., and an NDA & PhIII for Apaziquone.
One can get into a "chicken and the egg" debate... but the fact of the matter is that a.) SPPI leadership is out of favor with wall-street,.. partially due to the Fusilev debacle,.. partially related to setting & missing investor expectations on key milestones... and not being transparent enough -AND- b.) there is strong & growing short interest in SPPI...
That said,... the current stock price is dramatically suppressed due to the active & orchestrated shorting schemes. If the shorts were forced to cover, SPPI could potentially double.. maybe more depending on the level of new buying demand.
So, while I find it disturbing how the stock can get this low,... I'm continuing to acquire. I understand the "don't catch a falling knife philosophy".... but I'm seeing a significant disconnect between SPPI's intrinsic and extrinsic (market) valuations,.. and therefore, see an opportunity.
My perception is SPPI has become increasingly guarded about details of its programs for competitive reasons, not because they don't care about shareholders. Providing shareholders with complete transparency on pipeline development, clinical trials, etc. also tips off the competition... which is fierce.
As long as SPPI withholds info, and doesn't meet verbal commitments, we should continue to see the shorts make hay! This information black-out / delatys likely don't represent the company's fundamentals,.. but unfortunately causes fear, uncertainty, distrust (FUD)... providing the shorts ammunition.
There are drags on the shareprice,.. e.g. upcoming Fusilev judgement, the wait for the CE Melph NDA announcement, etc., The question is whether the company leadership is planning a surprise announcement(s) that could partially unseat the shorts... However, as long as SPPI "block and tackle".... i.e. deliver on their stated objectives,... I'll continue to buy.
Last Five Real-Time Trades
NLS Time (ET) NLS Price NLS Share Volume
13:52:26 $7.22 100
13:52:02 $7.221 100
13:51:58 $7.221 100
13:51:52 $7.22 100
13:51:51 $7.2201 100
I'm somewhat indifferent to the ebb and flow of sector- and macroeconomics.... I've historically invested in out of favor biotechs that have promising pipelines or drug candidates.... Did very well, but with SPPI's profile, it's a great opportunity to invest at a significant discount thanks to the short interest and lack of attention from Wall Street... AF said SPPI was "boring"... Comparing that with what he said about other companies I've invested in.... That's the most positive statement yet! I continue to acquire shares..... I.e. I'm taking the opposite side of the hedge fund's trade! Where are the short n distort rebuttals?
The **Majority** of Wall Street corruption goes unaddressed by the SEC..... The SEC threat to hedge funds is like posting a sign outside the unsecured hen house that reads: "Attention all foxes... We humanely catch and release all foxes... But don't touch the chickens!!"
Millennium should be investigated by the SEC for trading between multiple accounts.. and thereby manipulating the daily pps. However, the SEC is quite inept partially because of lack of staffing and technology, partially due to lack of expertise (hedge funds generally have smarter crooks working for them to devise and execute schemes to enrich themselves at the expense of investors than the talent the SEC has analysts to detect and prosecute it)....., and lastly, the concern that the SEC intentionally ignores the investigation and prosecution of various hedge fund activities due to relationships between SEC leadership and major Wall Street funds. Unfortunately, the SEC is a revolving door to Wall Street. Where do the SEC analysts and leadership come from? Wall Street firms! Where do SEC employees go when they leave? Wall Street firms! What's the definition of insanity?
Given the fundamentals and short interest.... I continue to add to my position..... Prediction: I see a very painful exit from the shorts!
Sentiment: Strong Buy
I can't believe that three trolls (or one troll with three IDs) would give you a thumbs down for what you said..... would like to see them receive a similar treatment without pain killers... or anesthesia
I'm going to be completely straight forward.... no ambiguities,... I sold my significant holdings of Inovio when I read that INO was going to go it alone on the PhIII HPV trial. The reason being was that I wanted to see INO follow their strategy of partnering their vaccine development programs as a risk mitigation move.
That said, my intent is to re-enter INO in the near future with a significant position,... I recently parked a fair position in SPPI... around 95k shares and am planning to hold this as a core position.... but really to park another $500k in INO asap.... maybe more.
I believed,.. and still believe in INO... There was a juncture where I moved some of my funds into SPPI... and I'm sleeping very well at night. I still expect INO to be bought out,... it will come when we least expect it. SPPI? I'm buying the stock... presumably big pharma is keeping SPPI in their sights as well.